Fieldable Solutions for Hemorrhage with bio-Artificial Resuscitation Products (FSHARP)

Archived

DARPA - Biological Technologies Office

Description

The goal of the FSHARP program is to leverage advances in bio-artificial blood substitute technologies to develop field deployable, shelf-stable hemorrhage countermeasures to sustain warfighters and civilian casualties in austere, pre-hospital settings.

Who can apply

  • Others

Contact

BAA Coordinator<br/>HR001121S0027@darpa.mil
HR001121S0027@darpa.mil

Key dates & funding
  • PostedMay 28, 2021
  • ClosesAug 10, 2021
  • CFDA12.910

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro